This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Robert Craig Melling and His Pharmaceutical Patent
Introduction
Robert Craig Melling is an inventor associated with Bayer Aktiengesellschaft. The supplied information places him in Oxfordshire, Great Britain, and identifies one patent associated with his work.
Latest Patents
Melling’s listed patent concerns the cholinate, or choline salt, of 2-(1-cyclobutyl-1H-pyrazol-4-yl)-5-[({1-[2-fluoro-4-(trifluoromethyl)-phenyl]cyclopropyl}carbonyl)amino]benzoic acid. The invention also covers the compound represented by formula (II), including its tautomers, solvates, and hydrates, and describes medical uses for the cholinate. The supplied data lists 1 patent for Melling.
Career Highlights
The patent connects Melling’s inventive work with pharmaceutical research at Bayer Aktiengesellschaft. Its focus on a specific choline salt and related forms reflects the patent’s emphasis on a defined chemical compound and its potential medical applications.
Collaborations
The supplied information names Stefan Bäurle and Hans-Georg Lerchen as Melling’s coworkers. Their inclusion indicates professional associations, although the available details do not specify their roles in this patent.
Conclusion
Robert Craig Melling is associated with a Bayer Aktiengesellschaft patent covering a pharmaceutical cholinate, its related forms, and potential medical uses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile